Skip to main content
Displaying 13 - 24 of 319
Display:
12
24
48
Metabolism, Alcohol & Toxicity
Linking the pathophysiology of MASH to its metabolic comorbidities
Webcasts
View
Metabolism, Alcohol & Toxicity
Q&A and closing remarks
Webcasts
View
Metabolism, Alcohol & Toxicity
Novo Nordisk: Navigating MASH patient care (Complete Session)
Webcasts
View
Metabolism, Alcohol & Toxicity
GSK: Meet the Experts - Genetic architecture of Steatotic Liver Disease (Complete Session)
Webcasts
View
Viral Hepatitis
GSK: Time to rethink chronic hepatitis B: A roadmap to functional cure (Complete Session)
Webcasts
View
Viral Hepatitis
GSK: Time to rethink chronic hepatitis B: Quantitative hepatitis B surface antigen today and tomorrow (Complete Session)
Webcasts
View
Metabolism, Alcohol & Toxicity
GSK: Unlocking the genetic architecture of Steatotic Liver Disease. A new paradigm in patient management (Complete Session)
Webcasts
View
Immune-Mediated and Cholestatic Diseases
GSK: Providing Better Care in PBC as a Patient-Based Clinician
Webcasts
View
Immune-Mediated and Cholestatic Diseases
GSK: Providing Better Care in PBC as a Patient-Based Clinician
Webcasts
View
Metabolism, Alcohol & Toxicity
Novo Nordisk: Personalised management of MASH (Complete Session)
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Gilead: Creating change today: Lowering risk, lowering burden of PBC in practice (Complete Session)
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Gilead: Creating change today: Lowering risk, lowering burden of PBC (Complete Session)
Webcasts
View
Pagination
First page
« First
Previous page
‹ previous
Page
1
Current page
2
Page
3
Page
4
Page
5
Page
6
Page
7
Page
8
Page
9
…
Next page
next ›
Last page
Last »
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy